Skip to main content
main-content

01.12.2013 | Research article | Ausgabe 1/2013 Open Access

BMC Palliative Care 1/2013

Paediatric palliative care: development and pilot study of a ‘Directory’ of life-limiting conditions

Zeitschrift:
BMC Palliative Care > Ausgabe 1/2013
Autoren:
Richard Hain, Mary Devins, Richard Hastings, Jayne Noyes
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1472-684X-12-43) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

RH conceived of the study, supervised the data collection and wrote the manuscript. MD carried out the data collection. RH, RHastings, MD and JN all developed the Directory itself, making amendments in various iterations. All authors participated in development of the final manuscript and have seen and approved the submitted draft.

Background

The need of children for palliative care is well recognised [ 19] but difficult to define. It is defined by the needs of an individual child and family when cure is no longer possible, rather than by age or organ system. The Royal College of Paediatrics and Child Health (RCPCH), working with the Association for Children’s Palliative Care (ACT) in 1997, defined the concept of life-limiting condition [ 6] through a series of archetype descriptions (Table  1), but did not attempt to name specific diagnoses except as exemplars. If, however, children are to have the same access to specialist palliative interventions as adults currently enjoy, service developers must engage commissioners. That requires a precise understanding of the numbers of children who need services, which in turn requires specific diagnostic criteria.
Table 1
ACT/RCPCH Categories[ 6]
Category
Key characteristic
Description
Examples
I
Potential for cure - life is threatened, not necessarily limited.
Conditions for which treatment may be feasible but can fail
Cancer
Some cardiac anomalies
II
Period of normality despite having fatal diagnosis.
Conditions where premature death is inevitable but where there may be long periods of participation in normal activities
Duchenne Muscular Dystrophy
III
Relentless deterioration from, or before, time of diagnosis.
Progressive conditions without curative treatment options, where treatment is exclusively palliative and commonly extends over many years
Metabolic or neurodegenerative conditions
IV
Unpredictable course whose progression is not easily judged from natural history.
Irreversible but non-progressive conditions causing likelihood of premature death through complications
Severe cerebral palsy
Traumatic brain injury
     
Septic brain injury
We developed a Directory of life-limiting conditions by mapping the four ACT/RCPCH archetypes onto the diagnoses of actual patients admitted to hospice or palliative care services in the UK. We then piloted the Directory by using it to interrogate death certificate data for children in Wales over a five-year period.
We describe development of the Directory and, in the light of results of the pilot study, consider some of its current limitations as well as the wider applications in taking forward service and research developments in children’s palliative care. The aim of this study was to develop and pilot a tool that can largely define the group of conditions that are life-limiting in childhood and facilitate secondary analysis of epidemiological data in this under-researched field.

Methods

Raw diagnostic data were collected

Diagnoses were obtained from patients under the care of five children’s hospices that were using a standardised data collection tool developed by Chase Hospice (Esplen, personal communication 2010), and the Welsh specialist paediatric palliative medicine service based at the Children’s Hospital in Cardiff. All had been considered to be ‘life-limiting’ both by the referring clinician and the clinician accepting the referral.

The list of diagnostic labels was refined

The list was edited in three ways.
Removal of duplicate diagnoses.
Duplicates occurred when two or more terms were used to describe the same condition (e.g., trisomy 13 and Patau’s syndrome).
Removal of non-diagnoses.
This included terms that had led to referral, but were not life limiting conditions in themselves. They included modes of death (e.g., apnoea), treatments for the life limiting diagnosis (e.g., tracheostomy) and conditions that were incidental to the life-limiting diagnosis (e.g., anaemia).
Removal of diagnoses that were not life-limiting.
For the purposes of this study, a life-limiting diagnosis was considered to be any condition whose trajectory could be described by one or more of the ACT/RCPCH archetypes (Table  1).

ICD10 codes were assigned to each diagnosis

A diagnostic label and code from the International Classification of Disease (ICD10) was assigned by the investigators to each diagnosis on the list (apps.who.int/classifications/apps/icd/icd10online/).

The draft directory was piloted using Welsh death certificate data

The draft Directory was used to interrogate a database comprising aggregated anonymous death certificate data for all deaths in Wales between 0 and 19 years between 2002 and 2007, obtained from Public Health Wales Observatory [ 10]. LLC that mapped onto one or more of the ACT/RCPCH archetypes but did not already appear in the draft Directory, were added to the draft.
This was a secondary analysis of data that were anonymous or already in the public domain that formed part of the My Choices project. Ethical approval for the project was obtained from the Betsi Cadwaldr NHS Research Ethics Committee.

Results

Development

1590 diagnoses from children’s hospices and 105 from specialist palliative medicine were combined. 1319 diagnoses were removed (see Methods section). All ICD10 chapter headings were represented by at least one condition, showing the range of conditions that can limit life in children.

Pilot study

There were 1052 deaths in childhood in Wales between 2002 and 2007 (Tables  1, 2 and 3). Of these, 569 (54%) were caused by LLC according to the Directory. Of 382 diagnoses listed causes of death on certificates, 186 (49%) were not LLC according to the Directory.
Table 2
Top five causes of death
Number of deaths
Diagnosis
ICD10 code
26
Cerebral palsy, unspecified
G80.9
22
Malignant neoplasm: Brainstem, brain (unspecified)
C71.7, C71.9
15
Acute leukaemia (lymphoblastic, myeloid)
C91.0, C92.0
11
Epilepsy, unspecified
G40.9
9
Muscular dystrophy
G71.0
These are causes of death that are describable by one of more of the ACT/RCPCH categories and therefore considered ‘life-limiting’ conditions.
Table 3
Top eleven diagnoses accounting for three or more deaths among neonates
Number of deaths
Diagnosis
ICD10 code
60
Birth asphyxia, unspecified
P21.9
19
Hypoplasia and dysplasia of lung
Q33.6
16
Necrotising enterocolitis of fetus and newborn
P77
16
Congenital diaphragmatic hernia
Q79.0
10
Edwards’ syndrome, unspecified
Q91.3
8
Congenital malformation of heart, unspecified
Q24.9
7
Persistent fetal circulation
P29.3
4
Congenital renal failure
P96.0
4
Hypoplastic left heart syndrome
Q23.4
3
Severe birth asphyxia
P21.0
3
Patau’s syndrome, unspecified
Q91.7
These are causes of death describable by one of more of the ACT/RCPCH categories and therefore considered ‘life-limiting’ conditions. In total, there were 169 deaths from 24 diagnoses.
According to the Directory, Death Certificate data recorded 169 deaths from life-limiting conditions (Table  3). 97% of which were accounted for by conditions in only two ICD10 chapters. Only four LLC resulted in ten or more deaths (Table  2). Among deaths from LLC, the ten commonest diagnoses accounted for 32%, while the 136 diagnoses that caused one or two deaths accounted for 25%. The majority occurred from a small number of life-limiting conditions. Malignancy (25%) and neurological conditions (21%) were the most frequent.

Discussion

Defining the population of children with life-limiting conditions accurately requires precise diagnoses. The aim of this study was to develop, and then to pilot, a list of life-limiting diagnoses in children that can be used for immediate secondary analysis of existing data.
In children, the term ‘life-limiting condition’ encompasses non-malignant as well as malignant conditions and the range of conditions is wide. LLC in children, especially in the UK, are conventionally classified by the ACT/RCPCH system [ 2, 5, 7, 9], which relies for its validity on assumed commonality among the courses of diseases within each of four categories. Limited evidence [ 11] supports this concept, but the ACT/RCPCH categories as they stand are too vague to be effective as registration criteria and need to be supplemented by identifying precise diagnoses. We are not, of course, the first to recognise the need for specific data in service development. Lists of life-limiting conditions have been compiled before, notably by Knapp (personal communication 2011), Craig [ 9] and Feudtner [ 12, 13].
The virtue of the ACT/RCPCH system is that it captures the diversity of conditions that can limit life; our aim was to obtain useful precise data without losing that virtue. For the purposes of this study, a life-limiting condition is therefore a condition whose trajectory is plausibly described by one or more of the ACT/RCPCH archetypes.
Diagnoses that emanated from hospices were not the same as those from specialist PPM services. Children’s hospices typically offer short respite stays and are often nurse-led. In contrast, specialist PPM services are based around availability of specialist medical services. Although the two populations clearly significantly overlap, they are not precisely co-terminous [ 14], and combining them therefore further expanded the number of diagnoses on the list.
It could be argued that some individual children with diagnoses that are not life-limiting conditions nevertheless require care that is, in effect, palliative. Traffic injuries [ 15], for example, do not fit an ACT/RCPCH category. For children with severe injuries that lead to death, however, PPM services could have a valuable role such as supporting end-of-life discussions in intensive care. Perhaps this indicates a potential value in extending the ACT/RCPCH categories to reflect the broader role that might be played by PPM services.
Conditions such as diabetes and epilepsy are usually incurable and often require the same approach and ‘ethos’ as palliative care. There is certainly a risk of drawing an arbitrary distinction between palliative care and what is simply good clinical practice in children. Nevertheless, those working in the field recognise a population of children within this wider group who are at high risk of death during childhood, and in whom complex symptom control is a frequent clinical challenge. It is that population that the Directory aims to help to identify.
There are inevitable limitations to a study of this nature. The ACT/RCPCH archetypes provide a measure of objectivity but still rely on a certain degree of subjective judgment. It is not possible to list every possible LLC in a Directory: the pilot study enabled us to add some diagnostic labels that might otherwise have been missed, but if the Directory is to remain current there will need to be a mechanism for adding new diagnoses as they become apparent.
Publically available data recorded on death certificates is limited to the principal causes of death. It is possible that small numbers of children with LLC who died from incidental causes were not identified in our pilot study.
In interpreting these results, it is important to make a distinction between diagnoses and patients. The Directory lists diagnoses. While it would not be valid to draw conclusions about number of children needing access to palliative care solely from observations of the number who actually do so, observations of service use do provide a valid source of diagnoses, since it is extremely likely (though not certain) that every important LLC would occur at least once. Similarly, the Directory is designed simply to provide a tool for analysing epidemiological data. It would be impossible to draw conclusions about the numbers of children suffering from life-limiting conditions from the Directory alone. Effective use of the Directory relies on applying it to databases that include accurate and detailed recording of ICD10 diagnostic labels to subheading level.
On the other hand, the Directory was easy to use and enabled the authors to interrogate a robust existing database effectively and immediately. We were able to make some important observations about LLC as causes of death in in Wales over a reasonable study period of five years. Most individual LLC caused only one death over that period and very few diagnoses (5 in neonates, 7 in older children) caused it 10 times or more (Tables  1 and 2). At the same time, nearly one third of deaths were accounted for by only ten different LLC, confirming clinicians’ impression that, while the range of possible LLC is wide, it is possible to identify a relatively small number of diagnoses whose symptom management should form the core of a specialist palliative care skillset. Of 420 deaths from LLC outside the neonatal period, 75% were from conditions other than cancer. This is higher than in studies that have relied on reporting by paediatricians [ 14], suggesting there has been under-recognition of the life-limiting nature of non-malignant conditions.
The Directory has a number of immediate practical applications where the sub-population of children with LLC needs to be identified within larger groups such as those with complex chronic disability or other chronic illness. It can rationally underpin fair admission and referral criteria for children’s hospice services, and help evaluate the magnitude of the need for specialist palliative medicine and palliative care services for children by institutions within the National Health Service. In countries such as the USA with a private healthcare system, the Directory can inform funding decisions among insurance companies. It can also facilitate robust governance and record-keeping by those providing palliative care, by allowing a definition of palliative care derived from a standard that has been largely agreed.
The Directory has potentially important applications for research in paediatric palliative care. To define the population of children needing palliative care in an essential first step in considering any research question that impacts specially on that group. The Directory has already been used for this purpose in research [ 16, 17] and service development [ 18]. Prevalence data, in particular, are key to rational service development, but for LLC there is no consistent relationship with incidence. Given the long natural history of LLC [ 11], it is usually impractical to obtain the prospective data needed to establish prevalence. The pilot study of the Directory shows that an agreed list of diagnoses potentially allows immediate secondary analysis of existing data.
Finally, the Directory can potentially allow critical evaluation of the ACT/RCPCH categories themselves, allowing amendments and improvements to what has become the standard definition of what constitutes a ‘life-limiting condition’.

Conclusions

The authors have compiled a ‘Directory’ of ICD10 diagnoses, drawing on admissions to children’s hospices on the one hand, and referrals to specialist paediatric palliative medicine on the other.
A pilot study of the Directory to analyse death certificate data showed that it was easy to use and allowed immediate secondary analysis of an established database. The study showed that around half of all childhood deaths in the study period were from LLC, thje majority of LLC are non-malignant, and that the range of LLC causing death in the neonatal period was markedly narrower than outside it.
By defining a list of precise ICD10 codes that map onto ACT/RCPCH criteria, for the first time the Directory allows analysis of existing clinical databases, paving the way for rapid establishment of prevalence data that would otherwise have been impractically slow.
No list of LLC based on disease label can ever be exhaustive. As new diagnoses become apparent, expansion will be important and should be the basis for further studies, which should also attach Read and ACT/RCPCH categories. While it will therefore continue to need refinement, the Directory is a key tool for rational service development in children’s palliative care.

Acknowledgement

The authors would like to thank Ms. Sonjia Ezergailis, Research Nurse at Children’s Hospice UK (now Together for Short Lives) who gathered diagnostic data from the children’s hospices, and all the data managers who participated. This project was part funded by Welsh Office of Research and Development (WORD), grant number ReF06/2/237.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License ( http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

RH conceived of the study, supervised the data collection and wrote the manuscript. MD carried out the data collection. RH, RHastings, MD and JN all developed the Directory itself, making amendments in various iterations. All authors participated in development of the final manuscript and have seen and approved the submitted draft.
Zusatzmaterial
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2013

BMC Palliative Care 1/2013 Zur Ausgabe

Neu im Fachgebiet AINS

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update AINS und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise